Common diabetes therapies may increase cancer risk, but more research needed
Common diabetes therapies may increase cancer risk, but more research needed
The benefits of using insulin to treat diabetes far outweigh the risks, but a review just published online by IJCP, the International Journal of Clinical Practice, suggests that commonly used diabetes therapies may differ from each other when it comes to their influence on cancer risk.
Read more on News-Medical-Net
Related posts: